Refining digital collaborationPharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to Share XRefining digital collaborationhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/pharma-hcp-digital-collaboration/
Blood Cancer UK: Hopes for our community’s future in the time of COVIDThis thought leadership series has been paid and developed by Kite, a Gilead Company. This Blood Cancer Awareness Share XBlood Cancer UK: Hopes for our community’s future in the time of COVIDhttps://pharmaphorum.com/oncology/blood-cancer-uk-hopes-for-our-communitys-future-in-the-time-of-covid/
Cancer research faces uncertain post-COVID landscapeThere’s a bright future ahead for cancer research in the UK, but only if the government is able Share XCancer research faces uncertain post-COVID landscapehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/cancer-research-faces-uncertain-post-covid-landscape/
Oncology and a year of COVID: lessons for the futureCOVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up Share XOncology and a year of COVID: lessons for the futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-and-a-year-of-covid-lessons-for-the-future/
How hybrid virtual engagement is accelerating oncology communicationCOVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement Share XHow hybrid virtual engagement is accelerating oncology communicationhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/how-hybrid-virtual-engagement-is-accelerating-oncology-communication/
Why pharma shouldn’t forget about sites in a post-COVID worldThe pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we Share XWhy pharma shouldn’t forget about sites in a post-COVID worldhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/why-pharma-shouldnt-forget-about-sites-in-a-post-covid-world/
Keeping clinical trial data safe – handling cybersecurity in a risky worldThe development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare. Share XKeeping clinical trial data safe – handling cybersecurity in a risky worldhttps://pharmaphorum.com/views-and-analysis/keeping-clinical-trial-data-safe-handling-cybersecurity-in-a-risky-world/
Inside the UK’s leading efforts to restart clinical researchA herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute Share XInside the UK’s leading efforts to restart clinical researchhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/inside-uks-leading-efforts-restart-clinical-research/
Pfizer files tick-borne encephalitis shot with FDAPfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the Share XPfizer files tick-borne encephalitis shot with FDAhttps://pharmaphorum.com/news/pfizer-files-tick-borne-encephalitis-shot-with-fda/
